VOGLIGOLD G3 M0.3

Living with type 2 diabetes often means that a single medicine stops being enough after a few years. Fasting sugar may creep up, post-meal readings may swing high after a plate of rice or roti, and the pancreas may no longer release enough insulin on its own. For many people in India, doctors respond by combining medicines that act in different ways. VOGLIGOLD G3 M0.3 from Steris Healthcare Pvt. Ltd. is one such triple-combination tablet, bringing together glimepiride, voglibose and metformin hydrochloride. This guide explains what it contains, why it matters, its benefits, precautions and side effects, and how to buy it responsibly.

Product Information 

Brand Name: VOGLIGOLD G3 M0.3
Composition: Glimepiride, Voglibose and Metformin Hydrochloride 
Manufacturer/Marketer: Steris Healthcare Pvt. Ltd.
Dosage Form: Tablet
Pack Size: 15 tablets
Drug Classes: Sulfonylurea + alpha-glucosidase inhibitor + biguanide
Therapeutic Category: Anti-diabetic (oral combination therapy)
Prescription Status: Prescription required (Rx)
Primary Use: Management of type 2 diabetes mellitus in adults when blood sugar is not adequately controlled with one or two anti-diabetic agents
Target Market: India

Please check the printed label and leaflet on your pack for the exact strengths, batch number, manufacturing and expiry dates, MRP and storage instructions. Prices vary by pharmacy and location, so confirm the current price when you buy.

What Is VOGLIGOLD G3 M0.3?

VOGLIGOLD G3 M0.3 is a fixed-dose combination of three well-established anti-diabetic ingredients. Each one targets a different part of the blood sugar problem.

Metformin hydrochloride is a biguanide and the most widely used first-line drug for type 2 diabetes. It reduces the amount of glucose released by the liver and improves how muscle and fat tissue respond to insulin.

Glimepiride is a sulfonylurea. It stimulates the beta cells of the pancreas to release more insulin, which lowers blood sugar, particularly around meals. Because it increases insulin release, it can cause low blood sugar if meals are delayed or skipped.

Voglibose is an alpha-glucosidase inhibitor. It acts in the small intestine and slows the digestion of complex carbohydrates, so glucose enters the blood gradually rather than in a sharp surge after eating.

Together, the three ingredients address insulin resistance, insulin availability and post-meal glucose absorption in a single tablet.

Why It Is Important

1. Type 2 diabetes is progressive. Over the years, insulin production tends to decline. Many patients need two or three medicines to remain within their HbA1c target, and a triple combination can be a practical option when two drugs are no longer enough.

2. It works on several causes at once. Insulin resistance, reduced insulin secretion and rapid carbohydrate absorption all contribute to high sugar. This combination acts on each of them.

3. Post-meal spikes are easy to miss and costly over time. Repeated high glucose after meals can contribute to damage in the eyes, kidneys, nerves and blood vessels. Voglibose is specifically useful in softening these spikes.

4. It suits carbohydrate-rich Indian diets. Rice, wheat, potatoes, sweets and snacks form a large share of daily calories in many households, which makes post-meal control especially relevant.

5. It can improve adherence. Research on chronic conditions consistently shows that simpler regimens are easier to follow. One tablet in place of three can reduce missed doses and daily confusion, particularly for older adults.

6. It may reduce pill burden and cost. For some patients, a single combination tablet can be more convenient and sometimes more economical than three separate medicines.

7. It supports long-term complication prevention. Keeping HbA1c within the target set by your doctor lowers the risk of neuropathy, retinopathy, kidney disease and cardiovascular problems.

Key Benefits 

• Stronger overall glycaemic control: Three complementary mechanisms help lower fasting and post-meal glucose when used as prescribed.
• Reduced post-meal glucose rise: Voglibose delays carbohydrate absorption and flattens peaks.
• Improved insulin sensitivity: Metformin helps the body use its own insulin more effectively.
• Enhanced insulin release: Glimepiride stimulates the pancreas, which helps when natural insulin production has fallen.
• Convenience: One tablet instead of three simplifies the daily routine.
• Established ingredients: Each component has been used for many years in India and around the world, so doctors have considerable experience with them.
• Useful step-up option: Doctors often consider triple combinations when monotherapy or dual therapy no longer maintains target levels.

No tablet works in isolation. Results are best when medicine is combined with a balanced diet, regular physical activity, adequate sleep, weight management and routine glucose monitoring.

How It Is Usually Taken

Your doctor will decide the dose and timing based on your blood sugar readings, kidney function, diet and other medicines. Combinations containing these ingredients are generally taken with or just before a meal, because voglibose works while food is being digested and metformin is better tolerated with food. Swallow the tablet with water, and do not crush or chew it unless your doctor says so. Do not skip meals after taking it, since glimepiride can cause low blood sugar when food is missed. If you miss a dose, do not take a double dose next time. Follow your prescription and the leaflet in the pack.

Precautions: What to Tell Your Doctor and Keep in Mind

Do not use this medicine if you:

• Have type 1 diabetes, diabetic ketoacidosis or diabetic coma
• Are allergic to glimepiride, voglibose, metformin, or to sulfonylurea or sulfonamide medicines
• Have severe kidney impairment or serious liver disease
• Have conditions that raise the risk of lactic acidosis, such as severe infection, dehydration, serious heart or lung failure or heavy alcohol use
• Have intestinal obstruction, severe inflammatory bowel disease or chronic digestive disorders affecting absorption

Use with caution and under medical supervision if you:

• Are elderly, because the risk of low blood sugar is higher
• Have mild to moderate kidney or liver problems
• Eat irregularly or skip meals often
• Have had abdominal surgery or bowel problems
• Are scheduled for surgery or a scan using contrast dye, as metformin may need to be paused temporarily
• Are pregnant, planning pregnancy or breastfeeding, since this type of combination is generally not recommended and your doctor may suggest insulin or another suitable option
• Take other medicines such as insulin, beta-blockers, certain antibiotics, fluconazole, NSAIDs, steroids, diuretics or herbal supplements, as these can change how the medicine acts

Practical safety advice:

• Check your blood glucose regularly and keep a log to share with your doctor.
• Learn the signs of low sugar: sweating, shaking, dizziness, hunger, confusion and fast heartbeat.
• Limit alcohol, which raises the risk of both hypoglycaemia and lactic acidosis.
• Take care when driving or operating machinery until you know how the medicine affects you.
• Get kidney function tests and vitamin B12 levels checked periodically, as long-term metformin use can lower B12.
• Include fibre in your diet and spread carbohydrates evenly across meals to reduce stomach symptoms.
• Tell every doctor, dentist and pharmacist that you take this combination.
• Never share your prescription medicines with others.

Possible Side Effects

Most people tolerate these medicines well, but side effects can occur, especially during the first few weeks.

Common side effects:

• Gas, flatulence and abdominal bloating (more typical with voglibose)
• Stomach discomfort or cramps
• Nausea, loose stools or diarrhoea
• Metallic taste in the mouth (metformin)
• Mild headache or dizziness
• Reduced appetite

Less common but important:

• Low blood sugar (hypoglycaemia), mainly due to glimepiride
• Weight gain (a sulfonylurea effect)
• Skin rash, itching or allergic reactions
• Constipation
• Vitamin B12 deficiency with long-term metformin use
• Changes in liver enzyme levels on blood tests

Many digestive symptoms ease as the body adjusts. If they persist or bother you, do not stop the medicine on your own. Talk to your doctor, who may adjust the dose or timing.

Frequently Asked Questions

1. What are glimepiride voglibose and metformin hydrochloride tablets?

Glimepiride, voglibose and metformin hydrochloride tablets are a fixed-dose combination anti-diabetic medicine used for adults with type 2 diabetes mellitus. They combine three drugs that work in different ways: metformin lowers glucose release from the liver and improves insulin sensitivity, glimepiride stimulates the pancreas to release more insulin, and voglibose slows carbohydrate absorption in the gut to reduce post-meal sugar spikes. Doctors usually prescribe this combination when one or two medicines are not keeping blood sugar within target. It is a prescription-only medicine.

2. What is the composition of glimepiride voglibose metformin tablets?

TRIOGLIMITERIS 1/0.2 contains:

• Voglibose 0.2 mg
• Glimepiride 1 mg
• Metformin Hydrochloride 500 mg

Other strengths of this combination may exist from different brands, so always check the label for the exact composition.

3. Which company manufactures glimepiride voglibose metformin tablets in India?

TRIOGLIMITERIS 1/0.2 is manufactured and marketed by Steris Healthcare Pvt. Ltd. Several other Indian pharmaceutical companies also market this combination under their own brand names. Confirm the manufacturer name, batch number and licence details printed on the pack.

4. Where can I find a supplier of glimepiride voglibose metformin tablets?

You can source these tablets through:

• Licensed retail chemists and hospital pharmacies (for personal use with a prescription)
• Registered pharmaceutical wholesalers and distributors
• Licensed online pharmacies that display a valid drug licence number
• The manufacturer directly, through its official website or business contact channels

Always verify the supplier’s drug licence (retail or wholesale), GST registration and physical address before ordering. Avoid sellers who do not ask for a prescription for retail purchases or who cannot show valid licences.

5. How can I buy glimepiride voglibose metformin tablets in bulk?

Bulk purchase is typically done through a licensed wholesaler, distributor or directly from the manufacturer or its authorised marketing team. Buyers such as pharmacies, hospitals, clinics and distributors usually need to provide:

• A valid wholesale or retail drug licence
• GST number and business details
• Required quantity and preferred pack size (for example, 15 tablets per strip)
• Delivery location

Ask for a proper tax invoice, batch details and expiry dates with every consignment. Individual patients should not buy in bulk without a doctor’s advice, because tablets have expiry dates and a prescription is required.

6. What is the price of glimepiride voglibose metformin tablets?

The price depends on the brand, strength, pack size, pharmacy and location. TRIOGLIMITERIS 1/0.2 is available in a pack of 15 tablets, and the printed MRP on the pack is the maximum retail price. Wholesale rates and discounts for bulk orders differ by supplier and order quantity. Please confirm the current price with the manufacturer, your local chemist or a licensed distributor, as prices can change.

7. Can pharmaceutical distributors order these tablets wholesale?

Yes, licensed pharmaceutical distributors and wholesalers can generally place wholesale orders with the manufacturer or its authorised channels. You will usually need to share your wholesale drug licence, GST details and territory or business information. Terms such as minimum order quantity, margins, credit period and delivery timelines are set by the company, so contact the marketer directly to discuss them.

8. Which pharmaceutical companies offer third-party manufacturing for these tablets?

Many Indian contract and loan-licence manufacturers produce oral anti-diabetic combinations for other brands, especially in pharma hubs such as Baddi, Himachal Pradesh; Haridwar, Uttarakhand; Ahmedabad and Vadodara, Gujarat; and Hyderabad, Telangana. Since I cannot verify which specific companies currently offer this exact combination, I recommend you:

• Check that the manufacturer holds a valid manufacturing licence and WHO-GMP or equivalent certification
• Ask for product-specific capability, minimum order quantity and stability data
• Review regulatory documents and visit the facility or request an audit where possible
• Confirm the combination’s approval status with the Indian drug regulator

Third-party manufacturing of a prescription fixed-dose combination must comply with CDSCO and state drug regulations.

9. How can I request a quotation for glimepiride voglibose metformin tablets?

To request a quotation, contact the manufacturer or a licensed supplier through their official email, phone number or enquiry form and include:

• Your company name and business type (distributor, pharmacy, hospital, etc.)
• Drug licence and GST numbers
• Product name and composition (Voglibose 0.2 mg, Glimepiride 1 mg, Metformin Hydrochloride 500 mg)
• Pack size and required quantity
• Delivery location and expected timeline

Request the quote in writing, and ask for the validity period, payment terms and applicable taxes.

10. Where can I find the product specifications for these tablets?

Product specifications are available from:

• The pack label and the package insert (leaflet) inside the carton
• The manufacturer’s official website or product catalogue
• The marketer’s sales or regulatory team on request
• Your pharmacist or prescribing doctor

Key details to check include composition, dosage form (tablet), pack size, storage conditions, shelf life, batch number and manufacturing and expiry dates. Distributors and institutional buyers can also request a product data sheet or certificate of analysis from the manufacturer.